VC-backed Complexa taps Liederman as chief business officer

Complexa, a clinical stage biopharmaceutical company, has named Dr. Elisabeth Leiderman as chief business officer.

7 February 2020•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Human Resources Briefs